Chemical structure and biological activity of the (1 →3)-linked β-D-glucan isolated from marine diatom Conticribra weissflogii

被引:13
作者
Rizzi, Juliane [1 ,2 ]
Moro, Tatiana Rojo [1 ,2 ,3 ]
Winnischofer, Sheila Maria Brochado [2 ]
Colusse, Guilherme Augusto [2 ,4 ]
Tamiello, Camila Silva [2 ]
Trombetta-Lima, Marina [3 ]
Noleto, Guilhermina Rodrigues [2 ]
Dolga, Amalia M. [3 ]
Duarte, Maria Eugenia Rabello [2 ]
Noseda, Miguel Daniel [2 ]
机构
[1] Univ Fed Parana, Postgrad Program Sci Biochem, Curitiba, PR, Brazil
[2] Univ Fed Parana, Dept Biochem & Mol Biol, Ave Cel Francisco H dos Santos 100,POB 19046, BR-81531980 Curitiba, PR, Brazil
[3] Univ Groningen, Fac Sci & Engn, Groningen Res Inst Pharm GRIP, Dept Mol Pharmacol, NL-9713 AV Groningen, Netherlands
[4] Univ Fed Parana, Postgrad Program Bioproc Engn & Biotechnol, Curitiba, PR, Brazil
关键词
Immunological activity; Glioblastoma; Microalga; Phagocytosis; Polysaccharide; MACROPHAGES; POLYSACCHARIDES; CANCER; GLIOMA; CHRYSOLAMINARAN; PHAGOCYTOSIS; INDUCTION; WATER;
D O I
10.1016/j.ijbiomac.2022.10.147
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several polysaccharides are considered to be "biological response modifiers" (BRM) - these refer to bio-molecules that augment immune responses and can be derived from a variety of sources. Microalgae produce a diverse range of polysaccharides and could be an excellent source of BRM. Here, we describe the chemical structure and biological activity of water-soluble polysaccharide isolated from the marine diatom Conticribra weissflogii. Using chemical and NMR spectroscopic methods, the polysaccharide was identified as a (1 -> 3)-linked beta-D-glucan with a low proportion of C-6 substitution by single beta-glucose units. The biological activity of this low molecular weight beta-glucan (11.7 kDa) was investigated with respect to glioblastoma cell lines (U87 MG and U251) and macrophages (RAW 264.7). We observed that this beta-D-glucan did not exhibit cytotoxic activity against glioblastoma cells, but did enhance the phagocytic activity of macrophages, suggesting that it possesses immunomodulatory properties.
引用
收藏
页码:584 / 593
页数:10
相关论文
共 67 条
[31]   Correlation between immunological activity, molar mass, and molecular structure of different (1->3)-beta-D-glucans [J].
Kulicke, WM ;
Lettau, AI ;
Thielking, H .
CARBOHYDRATE RESEARCH, 1997, 297 (02) :135-143
[32]   Molecular Interactions of β-(1 → 3)-Glucans with Their Receptors [J].
Legentil, Laurent ;
Paris, Franck ;
Ballet, Caroline ;
Trouvelot, Sophie ;
Daire, Xavier ;
Vetvicka, Vaclav ;
Ferrieres, Vincent .
MOLECULES, 2015, 20 (06) :9745-9766
[33]   Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation [J].
Li, Wenfang ;
Hu, Xueyan ;
Wang, Shuping ;
Jiao, Zeren ;
Sun, Tongyi ;
Liu, Tianqing ;
Song, Kedong .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 145 :985-997
[34]   Anti-tumor potential of astragalus polysaccharides on breast cancer cell line mediated by macrophage activation [J].
Li, Wenfang ;
Song, Kedong ;
Wang, Shuping ;
Zhang, Chenghong ;
Zhuang, Meiling ;
Wang, Yiwei ;
Liu, Tianqing .
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2019, 98 :685-695
[35]   Anti-tumor effect of polysaccharide from Hirsutella sinensis on human non-small cell lung cancer and nude mice through intrinsic mitochondrial pathway [J].
Liu, Wen-Bin ;
Xie, Fei ;
Sun, Hui-Qing ;
Meng, Meng ;
Zhu, Zhen-Yuan .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2017, 99 :258-264
[36]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[37]   STRUCTURAL STUDIES OF CHRYSOLAMINARAN FROM THE ICE DIATOM STAURONEIS-AMPHIOXYS (GREGORY) [J].
MCCONVILLE, MJ ;
BACIC, A ;
CLARKE, AE .
CARBOHYDRATE RESEARCH, 1986, 153 (02) :330-333
[38]   Induction of secretory and tumoricidal activities in peritoneal macrophages activated by an acidic heteropolysaccharide (ARAGAL) from the gum of Anadenanthera colubrina (Angico branco) [J].
Moretao, MP ;
Zampronio, AR ;
Gorin, PAJ ;
Iacomini, M ;
Oliveira, MBM .
IMMUNOLOGY LETTERS, 2004, 93 (2-3) :189-197
[39]  
Novak M., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P67
[40]  
OKAZAKI M, 1995, BIOL PHARM BULL, V18, P1320, DOI 10.1248/bpb.18.1320